Research progress of thalidomide in usual non-hematologic malignancies / 国际肿瘤学杂志
Journal of International Oncology
; (12): 711-714, 2016.
Article
in Zh
| WPRIM
| ID: wpr-497398
Responsible library:
WPRO
ABSTRACT
Thalidomide has anti-tumor effects such as anti-tumor angiogenesis,improvement of immune function and cachexia of patients with advanced tumors,which has been effectively used in elderly patients with castration-resistant prostate cancer,chemotherapy resistant advanced colorectal cancer,advanced hepatocellular carcinoma and metastatic breast cancer.As the in-depth study of the anti-tumor mechanism of thalidomide, more and more clinical researches have focused on the function of thalidomide on non-hematological malignan-cies,especially it has obtained some achivements in the postoperative adjuvant therapy for high-risk colorectal cancer and primary hepatocellular carcinoma and the salvage therapy for metastatic triple-negative breast cancer and refractory gynecological tumor.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of International Oncology
Year:
2016
Type:
Article